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General Procedures and Instrumentation. Reactions were carried out under an 
atmosphere of nitrogen. Nonacarbonyldiiron was dispensed in a glovebox, but all 
subsequent isolation and purification procedures were performed in a fumehood, open 
to the atmosphere. Solvents were dried and degassed by passing through anhydrous 
alumina columns using an Innovative Technology Inc. PS-400-7 solvent purification 
system. Petrol refers to petroleum ether, bp 40-60 °C. TLCs were performed using 
aluminum-backed plates precoated with Alugram®SIL G/UV and visualized by UV 
light (254 nm) and/or KMnO4 followed by gentle warming. Flash column 
chromatography was carried out using Davisil LC 60Å silica gel (35-70 micron) 
purchased from Fisher Scientifics. All reagents were purchased from Sigma-Aldrich 
and used as received. IR spectra were recorded on Perkin-Elmer 1600 FT IR 
spectrometer with absorbances quoted as ν in cm-1. NMR spectra were run in CDCl3 
on Brüker Avance 300, 400 or 500 MHz instruments at 298 K, unless otherwise 
specified. Mass spectra were recorded with a micrOTOF electrospray time-of-flight 
(ESI-TOF) mass spectrometer (Brüker Daltonik). Specific rotations were recorded on 
an Optical Activity AA-10 Automatic polarimeter with a path length of 1 dm. 
Concentrations (c) are quoted in g/100 mL. Elemental analysis was performed using 






















To known1 acetonide 7 (183 mg, 0.872 mmol, 1.00 equiv) in a glove box was added 
diiron nonacarbonyl (348 mg, 0.957 mmol, 1.09 equiv). THF (100 mL) was added 
and the reaction mixture was stirred at rt for 7 d. The reaction mixture was then added 
to an additional portion of diiron nonacarbonyl (409 mg, 1.29 equiv) via cannula. The 
reaction mixture was stirred at rt for an additional 9 d, then concentrated under 
reduced pressure (Care! Toxic pentacarbonyliron distilled over at this point). The 
crude brown oil was pre-adsorbed on silica and purified by chromatography (10% 
EtOAc-petroleum) to give (+)-(1R)-tricarbonyl(η4-(2R,3S)-methyl 2,3-
isopropylidenedioxycyclohexa-4,6-dienecarboxylate)iron(0) 9 (80.4 mg, 26%) as a 
yellow foam; crystals suitable for x-ray diffraction were grown by slow diffusion of 
hexane into a CH2Cl2 solution of 9; Rf 0.44 (10% EtOAc-petroleum); mp 81-84 ºC; 
[α]D25 +80º (c 0.1, CH2Cl2); δH (300 MHz, CDCl3, 298 K) 6.36 (1H, d, J 5.0 Hz, H-6) 
5.70 (1H, t, J 5.0 Hz, H-5) 5.12 (1H, d, J 8.5 Hz, H-2) 4.70 (1H, dd, J 8.5, 3.5 Hz, 
H-3) 3.72 (3H, s, -COOCH3) 3.11 (1H, t, J 5.0 Hz, H-4) 1.34 (3H, s, -OCH3) 1.22 
(3H, s, -OCH3); δC (100 MHz, toluene-d8, 228 K) [212.8, 206.7, 204.8] (Fe(CO)3), 
171.4 (-COOCH3), 114.6 (H3C-C-CH3), 89.8 (C-6), 86.7 (C-5), 75.6 (C-3), 73.9 
(C-2), 59.0 (C-4), 55.5 (-OCH3), 52.3 (C-1), 26.4 (-CH3), 24.6 (-CH3); νmax (film) 
2989, 2954, 2059, 1978, 1710, 1460, 1436, 1380, 1372, 1278, 1244, 1204, 1161, 
1043, 1006, 961, 916, 891, 802, 732, 667 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 
(C14H14FeO7+H)+, 351.0167, found 351.0164; calcd for (C14H14FeO7+Na)+, 372.9986, 



























To iron complex 9 (123 mg, 0.350 mmol, 1.0 equiv) and trimethylamine-N-oxide 10 
(1.05 g, 14.0 mmol, 39.9 equiv) under N2 was added benzene (50 mL). The reaction 
mixture was stirred at rt for 5 h. Diethyl ether (50 mL) was then added and precipitate 
was thoroughly dislodged from the flask walls with a spatula. The reaction mixture 
was transferred to a separating funnel and extracted with H2O (2 × 70 mL). The 
organic phase was dried over MgSO4 and filtered. The filtrate was concentrated under 
reduced pressure and dried under high vacuum to give (–)-(2S,3R)-methyl 2,3-
isopropylidenedioxycyclohexa-4,6-dienecarboxylate 11 (54 mg, 73%) as a light brown 
oil; Rf 0.48 (20% EtOAc-hexane); [α]D25 -108º (c 1.0, CH2Cl2); δH (400 MHz, CDCl3, 
298 K) 7.14 (1H, d, J 5.0 Hz, H-6), 6.12 (1H, dd, J 10.0, 2.5 Hz, H-4), 6.09 (1H, dd, J 
10.0, 5.0 Hz, H-5), 4.93 (1H, d, J 8.5 Hz, H-2), 4.87 (1H, dd, J 8.5, 2.5 Hz, H-3), 3.82 
(3H, s, -OCH3), 1.46 (3H, s, -CCH3), 1.39 (3H, s, -CCH3); data in agreement with 
those reported previously;2  δC (75.5 MHz, CDCl3, 298 K) 166.7 (-COOCH3), 134.0 
(C-4), 133.9 (C-6), 126.1 (C-1), 121.3 (C-5), 105.6 (H3C-C-CH3), 72.5 (C-3), 68.1 
(C-2), 52.1 (-OCH3), 26.7 (-CCH3), 25.1 (-CCH3); νmax (film) 2988, 2921, 1715, 1589, 
1437, 1371, 1297, 1259, 1161, 1108, 1082, 1030, 864, 707 cm-1; HRMS (+ve ESI-







Synthesis of (–)-(2S,3R)-(2,3-isopropylidenedioxycyclohexa-4,6-dienyl)methanol 
20 
 
Ester 11 (92 mg, 0.438 mmol, 1.0 equiv) was dissolved in diethyl ether (10 mL) under 
N2 at -78 °C. Lithium aluminium hydride (33.2 mg, 0.875 mmol, 2.0 equiv) in diethyl 
ether (10 mL) was added dropwise via cannula to the reaction mixture. The reaction 
mixture was stirred at 15 mins, then the dry ice/acetone bath was removed. The 
reaction mixture was then stirred for 10 mins, after which the reaction mixture was 
placed in an ice bath and ethyl acetate (2 mL) was added dropwise by syringe. The 
reaction mixture was stirred for a further 10 mins, then a saturated aqueous solution of 
Rochelle’s salt (30 mL) was added dropwise by syringe. The biphasic mixture was 
stirred vigorously and the ice bath was removed. After 1 h, an additional portion of 
diethyl ether (20 mL) was added and the mixture was transferred to a separating 
funnel. The layers were separated and the aqueous layer was extracted with additional 
portions of diethyl ether (4 × 30 mL). Combined organic phases were dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure and purified 
by chromatography (30% EtOAc-hexane) to give (–)-(2S,3R)-(2,3-
isopropylidenedioxycyclohexa-4,6-dienyl)methanol 20 (42.0 mg, 53%) as a colourless 
oil; Rf 0.21 (30% EtOAc-hexane); [α]D25 -75º (c 0.1, CH2Cl2); δH (400 MHz, CDCl3, 
298 K) 6.03 (1H, dd, J 9.5, 5.5 Hz, H-5), 5.97 (1H, dq, J 5.5, 1.0 Hz, H-6), 5.89 (1H, 
ddd, J 9.5, 1.5, 1.0 Hz, H-4), 4.73 (1H, d, J 7.5 Hz, H-2 or H-3), 4.70 (1H, d, J 9.5 Hz, 
H-2 or H-3), 4.32 (1H, d, J 14.0 Hz, -CHHOH), 4.29 (1H, d, J 14.0 Hz, -CHHOH), 
2.11 (1H, br s, -OH), 1.41 (3H, s, -CH3), 1.41 (3H, s, -CH3); δC (75.5 MHz, CDCl3, 
298 K) 136.1 (C-1), 124.6 (C-4), 124.0 (C-5), 119.5 (C-6), 105.5 (H3C-C-CH3), 71.8 
(C-2), 71.0 (C-3), 64.6 (-CH2OH), 26.8 (-CCH3), 24.8 (-CCH3); νmax (film) 3575, 
3416, 3044, 2985, 2930, 1611, 1541, 1406, 1371, 1304, 1246, 1207, 1158, 1033, 950, 
877, 820, 791, 756, 718, 694 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 




dienyl)methyl (2S)-3,3,3-trifluoro-2-methoxy-2-phenylpropionate 21 
 
Alcohol 20 (21.2 mg, 0.116 mmol, 1.0 equiv) and (2S)-3,3,3-trifluoro-2-methoxy-2-
phenylpropionate3 (54.5 mg, 0.233 mmol, 2.00 equiv, Aldrich #155616, 95% e.e.) 
were dissolved in CH2Cl2 (1.2 mL) at rt. N,N-Dimethylaminopyridine (2.5 mg, 0.020 
mmol, 0.09 equiv) in CH2Cl2 (0.3 mL) was added by syringe, followed by N,N’-
diisopropylcarbodiimide (29.4 mg, 0.233 mmol, 2.00 equiv). The reaction mixture 
was stirred at rt for 17 h, then concentrated under reduced pressure. A 1H-NMR 
spectrum of the crude was acquired, then purification by chromatography (30% 
EtOAc-hexane) gave (–)-(2’S,3’R)-(2’,3’-isopropylidenedioxycyclohexa-4’,6’-
dienyl)methyl (2S)-3,3,3-trifluoro-2-methoxy-2-phenylpropionate 21 (40 mg, 87%) as 
a white gum; Rf 0.68 (30% EtOAc-hexane); [α]D25 -30º (c 0.1, CH2Cl2); δH (400 MHz, 
CDCl3, 298 K) 7.53-7.52 (2H, m, Ar-H), 7.41-7.34 (3H, m, Ar-H), 6.01-5.97 (2H, m, 
H’-5, H’-6), 5.94-5.91 (1H, m, H’-4), 5.05 (1H, d, J 13.0 Hz, -CHH-O-), 4.89 (1H, d, 
J 13.0 Hz, -CHH-O-), 4.65 (1H, dd, J 9.0, 3.5 Hz, H’-3), 4.52 (1H, d, J 9.0 Hz, H’-2), 
3.56 (3H, s, -OCH3), 1.37 (6H, s, 2× C-CH3); δC (125.8 MHz, CDCl3, 298 K) 166.3 
(C=O), 132.2, 130.8, 130.1, 129.6, 128.7, 127.4, 126.9, 125.9, 123.3, 123.3 (q, 1JCF 
287 Hz, -CF3), 122.7, 105.6 (H3C-C-CH3), 84.7 (q, 2JCF 27 Hz, CCF3), 70.7, 70.5, 
66.6 (-CH2O-), 55.5 (-OCH3), 26.7 (-CCH3), 24.7 (-CCH3); δF (376.5 MHz, CDCl3, 
298 K) -71.5; νmax (film) 2968, 1754, 1452, 1372, 1171, 1122, 1017, 719, 642 cm-1; 
HRMS (+ve ESI-TOF) m/z calcd for (C20H21F3O5+Na)+, 421.1239, found 421.1238. 
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Synthesis of (+)-(2’S,3’R)-(2’,3’-isopropylidenedioxycyclohexa-4’,6’-
dienyl)methyl (2R)-3,3,3-trifluoro-2-methoxy-2-phenylpropionate 22 
 
Alcohol 20 (20.1 mg, 0.111 mmol, 1.0 equiv) and (2R)-3,3,3-trifluoro-2-methoxy-2-
phenylpropionate (60.0 mg, 0.256 mmol, 2.31 equiv, Aldrich #155268, 99% e.e.) 
were dissolved in CH2Cl2 (1.2 mL) at rt. N,N-Dimethylaminopyridine (2.0 mg, 0.016 
mmol, 0.15 equiv) in CH2Cl2 (0.3 mL) was added by syringe, followed by N,N’-
diisopropylcarbodiimide (28.0 mg, 0.222 mmol, 2.00 equiv). The reaction mixture 
was stirred at rt for 17 h, then concentrated under reduced pressure. A 1H-NMR 
spectrum of the crude was acquired, then purification by chromatography (20% 
EtOAc-hexane) gave (–)-(2’S,3’R)-(2’,3’-isopropylidenedioxycyclohexa-4’,6’-
dienyl)methyl (2R)-3,3,3-trifluoro-2-methoxy-2-phenylpropionate 22 (32 mg, 72%) as 
a white gum; Rf 0.58 (20% EtOAc-hexane); [α]D25 +10º (c 0.1, CH2Cl2); δH (400 
MHz, CDCl3, 298 K) 7.57-7.52 (2H, m, Ar-H), 7.44-7.36 (3H, m, Ar-H), 6.02-5.99 
(2H, m, H’-5, H’-6), 5.95-5.92 (1H, m, H’-4), 4.99 (1H, d, J 13.0 Hz, -CHH-O-), 4.94 
(1H, d, J 13.0 Hz, -CHH-O-), 4.62 (1H, dd, J 9.0, 3.5 Hz, H’-3), 4.51 (1H, d, J 9.0 Hz, 
H’-2), 3.58 (3H, s, -OCH3), 1.37 (3H, s, C-CH3), 1.36 (3H, s, C-CH3); δC (100.6 MHz, 
CDCl3, 298 K) 166.3 (C=O), 132.3, 130.7, 129.7, 129.6, 128.8, 127.3, 126.8, 125.8 
(q, 1JCF 276 Hz, -CF3), 125.8, 123.4, 122.9, 105.6 (H3C-C-CH3), 84.7 (q, 2JCF 27 Hz, 
-CCF3), 70.6, 70.4, 66.7 (-CH2O-), 55.6 (-OCH3), 26.7 (-CCH3), 24.7 (-CCH3); δF 
(376.5 MHz, CDCl3, 298 K) -71.5; νmax (film) 2988, 1749, 1672, 1498, 1452, 1372, 
1236, 1168, 1122, 1018, 766, 710, 655 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 
(C20H21F3O5+Na)+, 421.1239, found 421.1240. 
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Spectroscopic data for (1S,2R)-4-deutero-1,2-dihydroxycyclohexa-4,6-
dienecarboxylic acid 13 (deuterated analogue of 4) 
 
[α]D25 -90 (c 0.1, CH3OH); δH (300 MHz, CD3OD); 6.09 (1H, d, J 7.5 Hz, H-5), 5.80-
5.78 (2H, m, H-3, H-6), 4.85 (1H, br s, H-2); δC (100 MHz, CD3OD) 178.4, 133.9, 
127.7, 127.5, 123.7 (t, 1JCD 33.0 Hz), 75.9, 72.8; νmax (film) 3281, 3060, 2879, 1695, 
1576, 1397, 1357, 1330, 1309, 1267, 1221, 1171, 1150, 1078, 1050, 1008, 976, 912, 
877, 861, 803, 766, 750, 656 cm-1; HRMS (-ve ESI-TOF) m/z calcd for (C7H7DO4–
H)–, 156.0413; found 156.0412. 
 
Spectroscopic data for (+)-(1R)-Tricarbonyl(η4-(2R,3S)-methyl 4-deutero-2,3-
isopropylidenedioxycyclohexa-4,6-dienecarboxylate)iron(0) 15 (deuterated 
analogue of 9) 
 
 
δH (300 MHz, CDCl3); 6.36 (1H, d, J 4.5 Hz, H-6), 5.71 (1H, d, J 4.5 Hz, H-5), 5.13 
(1H, d, J 8.5 Hz, H-2), 4.71 (1H, d, J 8.5, H-3), 3.73 (3H, s, -COOCH3), 1.35 (3H, s, 
C-CH3), 1.23 (3H, s, C-CH3); δC (75.4 MHz, CDCl3) 171.2, 114.8, 89.7, 86.7, 76.3, 
74.6, 60.3, 52.0, 27.0, 25.4; νmax (film) 2988, 2936, 2060, 1982, 1713, 1458, 1437, 
1373, 1338, 1318, 1298, 1262, 1244, 1205, 1160, 1095, 1064, 1012, 961, 905, 878, 






Formation of (2S,3R)-methyl 2,3-dihydroxycyclohexa-4,6-dienecarboxylate 11 
observed by NMR. 
 
Isopropylidene 11 (22.0 mg, 0.105 mmol, 1.0 equiv) was dissolved in CD3OD (1 mL) 
in a Young’s NMR tube. Iodine (15.4 mg, 0.0607 mmol, 0.58 equiv) was added. The 
NMR sample was heated to 50 °C and 1H-NMR spectra were acquired at five minute 
intervals (Fig. S1, diagnostic regions shown). Formation of diol 12 was observed, but 
before all isopropylidene 11 had been consumed, aromatic dehydration byproduct 23 
was observed to form. Subsequently all material was converted to 23. 
6.957.007.057.107.15 ppm 3.803.823.843.863.88 ppm
t = 0 min 
t = 95 min 
 
Fig. S1 Dynamic NMR of iodine-mediated deprotection of 11. Spectra are at 5 min intervals. 






















t = 95 min 
t = 70 min 
t = 0 min 
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Variable temperature 13C{1H} spectra for lineshape analysis were acquired on a 
Brüker Avance 400 MHz spectrometer, operating at 100.6 MHz for 13C, using 
toluene-d8 as solvent and allowing at least 15 minutes for equilibration at each 
temperature. Spectra were calibrated to internal solvent at 20.4 ppm. Temperatures 
were calibrated using an external sample of either methanol or ethylene glycol,4  
acquired under identical conditions. Spectra were simulated using DNMR (Brüker)5  
and gNMR,6 assuming a tripodal rotation and using the CO2Me resonance to provide 
an estimate for the natural linewidth in the absence of exchange. At and above the 
coalescence temperature the chemical shifts for the 3 exchanging carbonyl ligands 
were estimated from their variation below the coalescence temperature:7  the 
resonance at ca. 208 ppm was found to have a linear dependence on temperature, 
which was extrapolated to temperatures above coalescence; the resonances at ca. 214 
and 206 ppm did not show a well-defined change with temperature and were fixed (to 
within 0.08 ppm) of the chemical shift below coalescence. 
The rate constants, k, obtained from the simulations (Fig. S3) were used in plots (Fig. 
S4) of ln(k) versus T and ln (k/T) versus T to obtain values for the activation 

















































Fig. S3 Experimental (left) and simulated (right) variable temperature 13C{1H} NMR spectra of complex 9, 
at 100.6 MHz in toluene-d8, showing the iron carbonyl region only. Rate constants (in s-1) are given 
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Fig S4 Plots of (a) ln (k) vs T-1 and (b) ln (k/T) vs T-1 for the carbonyl exchange in complex 9. 
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Crystal Data for 9. 
 
Table S1.  Crystal data and structure refinement for 9. 
Empirical formula  C14 H14 Fe O7 
Formula weight  350.10 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21
Unit cell dimensions a = 10.1710(4) Å α= 90°. 
 b = 7.2170(4) Å β= 110.426(3)°. 
 c = 10.6320(6) Å γ = 90°. 
Volume 731.36(6) Å3 
Z 2 
Density (calculated) 1.590 Mg/m3 
Absorption coefficient 1.063 mm-1 
F(000) 360 
Crystal size 0.22 x 0.17 x 0.13 mm3 
Theta range for data collection 8.57 to 30.45°. 
Index ranges -14<=h<=14, -10<=k<=10, -15<=l<=15 
Reflections collected 6719 
Independent reflections 3638 [R(int) = 0.0689] 
Completeness to theta = 30.45° 93.2 %  
Absorption correction None 
Max. and min. transmission 0.8742 and 0.7998 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3638 / 1 / 203 
Goodness-of-fit on F2 1.032 
Final R indices [I>2sigma(I)] R1 = 0.0380, wR2 = 0.1027 
R indices (all data) R1 = 0.0398, wR2 = 0.1044 
Absolute structure parameter -0.007(16) 
Extinction coefficient 0.068(13) 
Largest diff. peak and hole 0.362 and -0.628 e.Å-3 
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Table S2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for 9.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
Fe(1) -1413(1) 1264(1) -8094(1) 19(1) 
O(1) 816(2) -1126(3) -6359(2) 38(1) 
O(2) -49(3) 4784(3) -6994(3) 43(1) 
O(3) -582(2) 1747(4) -10467(2) 45(1) 
O(4) -2697(2) -3869(3) -9759(2) 28(1) 
O(5) -2932(2) -1312(3) -11033(2) 25(1) 
O(6) -4069(2) -723(3) -6164(2) 26(1) 
O(7) -4312(2) -2720(3) -7869(2) 22(1) 
C(1) -48(3) -209(4) -7052(3) 25(1) 
C(2) -585(3) 3437(4) -7463(3) 27(1) 
C(3) -933(3) 1515(5) -9584(3) 28(1) 
C(11) -2873(2) -915(3) -8810(2) 18(1) 
C(12) -3521(2) 871(3) -9169(2) 19(1) 
C(13) -3358(2) 2093(3) -8080(2) 21(1) 
C(14) -2557(2) 1388(4) -6781(2) 22(1) 
C(15) -2767(2) -574(3) -6411(2) 19(1) 
C(16) -2952(2) -1913(3) -7588(2) 19(1) 
C(17) -2817(2) -2210(3) -9881(2) 19(1) 
C(18) -2957(3) -2487(4) -12142(3) 28(1) 
C(19) -4666(3) -2481(3) -6694(2) 22(1) 
C(20) -6245(3) -2363(4) -7108(3) 32(1) 
C(21) -4036(3) -4034(4) -5700(2) 30(1) 
________________________________________________________________________________
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Table S3.   Bond lengths [Å] and angles [°] for 9. 
_____________________________________________________ 
 
Fe(1)-C(1)  1.793(3) 
Fe(1)-C(2)  1.796(3) 
Fe(1)-C(3)  1.823(3) 
Fe(1)-C(12)  2.067(2) 
Fe(1)-C(13)  2.071(2) 
Fe(1)-C(14)  2.108(2) 
Fe(1)-C(11)  2.114(2) 
O(1)-C(1)  1.140(3) 
O(2)-C(2)  1.140(4) 
O(3)-C(3)  1.126(3) 
O(4)-C(17)  1.206(3) 
O(5)-C(17)  1.354(3) 
O(5)-C(18)  1.445(3) 
O(6)-C(19)  1.434(3) 
O(6)-C(15)  1.441(3) 
O(7)-C(19)  1.426(3) 
O(7)-C(16)  1.433(3) 
C(11)-C(12)  1.437(3) 
C(11)-C(17)  1.490(3) 
C(11)-C(16)  1.511(3) 
C(12)-C(13)  1.418(3) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.430(3) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.505(4) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.540(3) 
C(15)-H(15)  1.0000 
C(16)-H(16)  1.0000 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
C(19)-C(20)  1.512(4) 
C(19)-C(21)  1.520(4) 
C(20)-H(20A)  0.9800 
C(20)-H(20B)  0.9800 
C(20)-H(20C)  0.9800 
C(21)-H(21A)  0.9800 
C(21)-H(21B)  0.9800 

































































































Table S4.   Anisotropic displacement parameters (Å2x 103)for 9.  The anisotropic 
displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
Fe(1) 18(1)  17(1) 19(1)  0(1) 4(1)  -1(1) 
O(1) 26(1)  34(1) 44(1)  8(1) 0(1)  4(1) 
O(2) 40(1)  25(1) 54(1)  -5(1) 4(1)  -8(1) 
O(3) 39(1)  67(2) 32(1)  1(1) 15(1)  -13(1) 
O(4) 42(1)  19(1) 25(1)  -1(1) 14(1)  2(1) 
O(5) 40(1)  21(1) 17(1)  -3(1) 12(1)  0(1) 
O(6) 28(1)  24(1) 31(1)  -12(1) 16(1)  -6(1) 
O(7) 25(1)  24(1) 16(1)  -3(1) 6(1)  -6(1) 
C(1) 21(1)  24(1) 28(1)  -2(1) 7(1)  -4(1) 
C(2) 27(1)  23(1) 30(1)  1(1) 8(1)  -2(1) 
C(3) 22(1)  35(2) 27(1)  0(1) 7(1)  -4(1) 
C(11) 20(1)  17(1) 15(1)  -2(1) 4(1)  -1(1) 
C(12) 19(1)  17(1) 19(1)  -1(1) 6(1)  1(1) 
C(13) 22(1)  18(1) 24(1)  -2(1) 7(1)  2(1) 
C(14) 23(1)  22(1) 20(1)  -4(1) 6(1)  -4(1) 
C(15) 21(1)  22(1) 16(1)  -3(1) 6(1)  -2(1) 
C(16) 19(1)  18(1) 16(1)  -1(1) 4(1)  0(1) 
C(17) 20(1)  20(1) 17(1)  -1(1) 6(1)  0(1) 
C(18) 41(1)  26(1) 22(1)  -6(1) 15(1)  -1(1) 
C(19) 25(1)  19(1) 23(1)  -6(1) 11(1)  -3(1) 
C(20) 25(1)  24(1) 51(2)  -10(1) 18(1)  -2(1) 










7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
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